price athena health stock

Is Athena technology acquisition a blank check company?

About Athena Technology Acquisition Corp Athena Technology Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.

Should you buy Athira Pharma (Atha) stock?

Investors need to pay close attention to Athira Pharma (ATHA) stock based on the movements in the options market lately. What Kind Of Shareholders Own Athira Pharma, Inc. (NASDAQ:ATHA)? A look at the shareholders of Athira Pharma, Inc. ( NASDAQ:ATHA ) can tell us which group is most powerful. Generally...

What does athenahealth do?

athenahealth, Inc. develops health care software. The Company offers revenue cycle management services that automates and manages billing-related functions for practice management platform. athenahealth serves customers in the United States.

What is the Athira Pharma class-action lawsuit?

The Athira Pharma class-action lawsuit alleges that, throughout the Class Period, d Leen Kawas resigned from her post as Athira CEO after an investigation found she manipulated data in papers — and ATHA stock soared.

See more

Is Athena technology a good investment?

Investing in stocks, such as Athena Technology, is an excellent way to grow wealth. For long-term investors, stocks are a good investment even during periods of the market volatility - a stock market downturn means that many stocks are on sale.

Who owns Athena Health Care?

Athenahealth has been acquired by private equity firms Hellman & Friedman and Bain Capital for $17 billion.

What is Aetna stock price today?

AET Price/Volume StatsCurrent price$212.7052-week highDay low$211.79VolumeDay high$213.36Avg. volume50-day MA$203.39Dividend yield200-day MA$188.39Market Cap1 more row

What is a Stock market Cap?

Market cap—or market capitalization—refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares. For example, a company with 20 million shares selling at $50 a share would have a market cap of $1 billion.

Is Athena health publicly traded?

Athenahealth was publicly traded until 2019, when it was sold to Veritas Capital, a New York private-equity firm, and Evergreen Coast Capital, the private-equity unit of the activist hedge fund Elliot Management, for $5.7 billion. The companies merged athenahealth with Virence Health, a healthcare IT company.

Who are athenahealth competitors?

athenahealth competitors include Allscripts Healthcare Solutions, Orion Health and Ciox health.

Does CVS own Aetna?

CVS Health-owned Aetna on Monday rolled out a plan design that would steer patients toward its parent company's brick-and-mortar locations — a key concern of antitrust regulators in reviewing the almost $69 billion megamerger that closed in 2019.

Is Aetna a good stock to buy?

Is Aetna a good dividend stock? Aetna(NYSE:AET) pays an annual dividend of $2.00 per share and currently has a dividend yield of 0.94%. The dividend payout ratio of Aetna is 20.28%. This payout ratio is at a healthy, sustainable level, below 75%.

Did CVS merge with Aetna?

CVS completes its acquisition of Aetna.

Which is the richest company in the world 2021?

AppleThe stock's 30% growth this year added $659.8 billion to its market cap. Apple remains the most valuable company in the world by roughly $400 billion.

Which is the biggest stock market in the world?

The New York Stock ExchangeThe New York Stock Exchange is the largest stock exchange in the world, with an equity market capitalization of just over 25.2 trillion U.S. dollars as of May 2022. The following three exchanges were the NASDAQ, the Shanghai Stock Exchange, and the Euronext.

What is the most expensive company in the world?

Saudi Aramco is currently the world's most valuable company.

Is Athena health legit?

Athena Health is the secure Electronic Health Record (EHR) program that Oaklawn Medical Group uses to hold and store all the personal health information of our patients. It is also the program that is used by medical group patients to pay their bills online. Athena Health QuickPay Portal is fully protected.

What happened Athena health?

After fielding numerous interested parties, Athenahealth was acquired by Elliot's PE arm Veritas and Evergreen in 2019 for about $5.7 billion following an acrimonious activist campaign led by Elliot that eventually resulted in the departure of Athenahealth's co-founder and former chief executive, Jonathan Bush.

Who is CEO of athenahealth?

Bob Segert (Feb 2019–)Athenahealth / CEO

Will Cerner be acquired?

Oracle Corporation (NYSE: ORCL) announced that a majority of the outstanding shares (the “Shares”) of Cerner Corporation (Nasdaq: CERN) were validly tendered, and the other conditions to the tender offer have been satisfied or waived. The deal will close on June 8, 2022.

Signals & Forecast

Support, Risk & Stop-loss

The athenahealth stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average.

Is athenahealth stock A Buy?

athenahealth finds support from accumulated volume at $133.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

Insiders are very positive buying more shares than they are selling in athenahealth

athenahealth holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

About athenahealth

In the last 100 trades there were 45.93 million shares bought and 6.76 million shares sold. The last trade was done 50 days ago by Gross William who bough 4.21 million shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.

Golden Star Signal

athenahealth, Inc., together with its subsidiaries, provides cloud-based services and mobile applications for medical groups and health systems. The company provides services through athenaNet, a cloud-based platform.

Top Fintech Company

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Funding

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Funding Rounds

Athenahealth has raised a total of $40M in funding over 4 rounds. Their latest funding was raised on May 18, 2017 from a Post-IPO Equity round. Athenahealth is registered under the ticker NASDAQ:ATHN . Their stock opened with $18.00 in its Sep 20, 2007 IPO. Athenahealth is funded by 3 investors.

IPO & Stock Price

Athenahealth has raised a total of $40M in funding over 4 rounds. Their latest funding was raised on May 18, 2017 from a Post-IPO Equity round.

Investors

Athenahealth is registered under the ticker NASDAQ:ATHN . Their stock opened with $18.00 in its Sep 20, 2007 IPO.

Investments

Athenahealth is funded by 3 investors. NAI Elliott and GGV Capital are the most recent investors.

Acquisitions

Athenahealth has invested in PatientPop on May 13, 2015. This investment - Seed Round - PatientPop - was valued at $3M.

Athira Pharma to Present Preclinical Data at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting

Athenahealth has acquired 8 organizations. Their most recent acquisition was Praxify on Jun 8, 2017. They acquired Praxify for $63M.

Athira Pharma Announces Publication of Phase 1 Results for Fosgonimeton (ATH-1017) in The Journal of Alzheimer's Disease

Oral presentation on neurotrophic and procognitive properties of the active metabolite of fosgonimeton in preclinical models First presentation of preclinical data from ATH-1020 candidate for neuropsychiatric conditions BOTHELL, Wash., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc.

Laird Norton Trust Company, Llc Buys iShares National Muni Bond ETF, iShares Core S&P 500 ..

Fosgonimeton demonstrated a statistically significant improvement of Event-Related Potential (ERP) P300 latency as compared with placebo in Alzheimer’s disease patients Fosgonimeton was well-tolerated across all dose levels and showed dose-proportional pharmacokinetics and encouraging pharmacodynamic activity Announces fosgonimeton as World Health Organization’s recommended international nonproprietary name for ATH-1017 BOTHELL, Wash., Feb.

Athira Pharma appoints new board member

Investment company Laird Norton Trust Company, Llc (Current Portfolio) buys iShares National Muni Bond ETF, iShares Core S&P 500 ETF, Airbnb Inc, ACV Auctions Inc, Athira Pharma Inc, sells MSCI USA ESG Select ETF, Vanguard S&P 500 ETF, iShares S&P 500 Growth ETF, Vanguard Growth ETF, FlexShares Global Quality FlexShares Global Qualit during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Laird Norton Trust Company, Llc..

Athira Pharma Announces Appointment of Grant Pickering to its Board of Directors

The Bothell-based biotech has appointed Grant Pickering, CEO and co-founder of Vaxcyte, to its board following a tumultuous 2021.

Athira Pharma Announces Initiation of Patient Dosing in SHAPE, a Phase 2 Clinical Trial of ATH-1017 for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies

BOTHELL, Wash., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced the appointment of Grant Pickering to its Board of Directors. Mr.

Athira Pharma Provides 2022 Pipeline Outlook

BOTHELL, Wash., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc.